KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Operating Margin (2018 - 2025)

Vir Biotechnology's Operating Margin history spans 8 years, with the latest figure at 74.79% for Q4 2025.

  • On a quarterly basis, Operating Margin rose 87195.0% to 74.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 699.18%, a 14531.0% increase, with the full-year FY2025 number at 699.18%, up 9210.0% from a year prior.
  • Operating Margin hit 74.79% in Q4 2025 for Vir Biotechnology, up from 72267.92% in the prior quarter.
  • Over the last five years, Operating Margin for VIR hit a ceiling of 82.26% in Q1 2022 and a floor of 72267.92% in Q3 2025.
  • Historically, Operating Margin has averaged 6258.75% across 5 years, with a median of 691.23% in 2022.
  • Biggest five-year swings in Operating Margin: skyrocketed 811025bps in 2022 and later crashed -6254926bps in 2025.
  • Tracing VIR's Operating Margin over 5 years: stood at 70.35% in 2021, then crashed by -533bps to 304.6% in 2022, then plummeted by -172bps to 828.12% in 2023, then fell by -14bps to 946.74% in 2024, then surged by 92bps to 74.79% in 2025.
  • Business Quant data shows Operating Margin for VIR at 74.79% in Q4 2025, 72267.92% in Q3 2025, and 9754.28% in Q2 2025.